Pain
- Anti-Ulcerants
- Antibacterials
- Antibiotics
- Anticoagulants
- Antidiabetics
- Antifungals
- Antivirals
- Autoimmune Disease Drugs
- Biologics
- Biosimilars
- Cardiovascular Drugs
- Cellular Therapeutics
- Combination Therapies
- Dermatologic Drugs
- Enzyme Replacement Therapy
- Generics
- Hormone Replacement Therapy
- Immuno-oncology
- Immunotherapies
- Lipid Regulators
- Mental Health Drugs
- Oncologics
- Orphan Drugs
- Pain
- Protein Therapeutics
- Psychoactive Drugs
- Radiopharmaceuticals
- Respiratory Drugs
- Traditional Chinese Medications
- Vaccines
![Acquired firm will add $400M to annualized revenues. [© frenta - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/Sept28_2010_8232965_LittleMenPushPuzzlePieces_EndoBuysQualitest3618119845-265x198.jpg "Endo to Buy Qualitest for $1.2B to Bolster Generics Business and Pain Portfolio")
![Pain Therapeutics is the frontrunner with over $2 million to advance research in CNS diseases and oncology. [Natalia Merzlyakova - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/Nov2_2010_21268832_100DollarBillUnderMicroscope_ManyFirmsWinMoneyforQTDP6519238781-324x160.jpg "Qualifying Therapeutic Discovery Project Doles Out More Than $17M")
